These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 21930755)

  • 1. Genotypic and phenotypic variation in Pseudomonas aeruginosa reveals signatures of secondary infection and mutator activity in certain cystic fibrosis patients with chronic lung infections.
    Warren AE; Boulianne-Larsen CM; Chandler CB; Chiotti K; Kroll E; Miller SR; Taddei F; Sermet-Gaudelus I; Ferroni A; McInnerney K; Franklin MJ; Rosenzweig F
    Infect Immun; 2011 Dec; 79(12):4802-18. PubMed ID: 21930755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: strong and weak mutators with heterogeneous genetic backgrounds emerge in mucA and/or lasR mutants.
    Ciofu O; Mandsberg LF; Bjarnsholt T; Wassermann T; Høiby N
    Microbiology (Reading); 2010 Apr; 156(Pt 4):1108-1119. PubMed ID: 20019078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal dissemination, emergence of mutator lineages and antibiotic resistance evolution in Pseudomonas aeruginosa cystic fibrosis chronic lung infection.
    López-Causapé C; Rojo-Molinero E; Mulet X; Cabot G; Moyà B; Figuerola J; Togores B; Pérez JL; Oliver A
    PLoS One; 2013; 8(8):e71001. PubMed ID: 23951065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Great phenotypic and genetic variation among successive chronic Pseudomonas aeruginosa from a cystic fibrosis patient.
    Lozano C; Azcona-Gutiérrez JM; Van Bambeke F; Sáenz Y
    PLoS One; 2018; 13(9):e0204167. PubMed ID: 30212579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study.
    López-Causapé C; de Dios-Caballero J; Cobo M; Escribano A; Asensio Ó; Oliver A; Del Campo R; Cantón R; Solé A; Cortell I; Asensio O; García G; Martínez MT; Cols M; Salcedo A; Vázquez C; Baranda F; Girón R; Quintana E; Delgado I; de Miguel MÁ; García M; Oliva C; Prados MC; Barrio MI; Pastor MD; Olveira C; de Gracia J; Álvarez A; Escribano A; Castillo S; Figuerola J; Togores B; Oliver A; López C; de Dios Caballero J; Tato M; Máiz L; Suárez L; Cantón R
    Int J Antimicrob Agents; 2017 Sep; 50(3):334-341. PubMed ID: 28735882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants.
    Oliver A; Baquero F; Blázquez J
    Mol Microbiol; 2002 Mar; 43(6):1641-50. PubMed ID: 11952911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation.
    Mena A; Smith EE; Burns JL; Speert DP; Moskowitz SM; Perez JL; Oliver A
    J Bacteriol; 2008 Dec; 190(24):7910-7. PubMed ID: 18849421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucoidy, quorum sensing, mismatch repair and antibiotic resistance in Pseudomonas aeruginosa from cystic fibrosis chronic airways infections.
    Feliziani S; Luján AM; Moyano AJ; Sola C; Bocco JL; Montanaro P; Canigia LF; Argaraña CE; Smania AM
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strains.
    Varga JJ; Barbier M; Mulet X; Bielecki P; Bartell JA; Owings JP; Martinez-Ramos I; Hittle LE; Davis MR; Damron FH; Liechti GW; Puchałka J; dos Santos VA; Ernst RK; Papin JA; Albertí S; Oliver A; Goldberg JB
    BMC Genomics; 2015 Oct; 16():883. PubMed ID: 26519161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed with cystic fibrosis following newborn screening.
    Hu H; Harmer C; Anuj S; Wainwright CE; Manos J; Cheney J; Harbour C; Zablotska I; Turnbull L; Whitchurch CB; Grimwood K; Rose B;
    Clin Microbiol Infect; 2013 Mar; 19(3):266-72. PubMed ID: 22329595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis.
    Hoboth C; Hoffmann R; Eichner A; Henke C; Schmoldt S; Imhof A; Heesemann J; Hogardt M
    J Infect Dis; 2009 Jul; 200(1):118-30. PubMed ID: 19459782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis.
    Hogardt M; Hoboth C; Schmoldt S; Henke C; Bader L; Heesemann J
    J Infect Dis; 2007 Jan; 195(1):70-80. PubMed ID: 17152010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virulence factor expression patterns in Pseudomonas aeruginosa strains from infants with cystic fibrosis.
    Manos J; Hu H; Rose BR; Wainwright CE; Zablotska IB; Cheney J; Turnbull L; Whitchurch CB; Grimwood K; Harmer C; Anuj SN; Harbour C;
    Eur J Clin Microbiol Infect Dis; 2013 Dec; 32(12):1583-92. PubMed ID: 23832143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution and adaptation in Pseudomonas aeruginosa biofilms driven by mismatch repair system-deficient mutators.
    Luján AM; Maciá MD; Yang L; Molin S; Oliver A; Smania AM
    PLoS One; 2011; 6(11):e27842. PubMed ID: 22114708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance.
    Oliver A; Mena A
    Clin Microbiol Infect; 2010 Jul; 16(7):798-808. PubMed ID: 20880409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomonas aeruginosa Isolates From a Cohort of Mexican Children With Cystic Fibrosis Show Adaptation to a Chronic Phenotype.
    Rosales-Reyes R; Rodríguez-Alvarado M; Lezana-Fernández JL; Sánchez-Lozano JY; Gayosso-Vázquez C; Jarillo-Quijada MD; Toledano-Tableros JE; Arredondo-Mercado MJ; Alcántar-Curiel MD; Lincopan N; Vidal JE; Lascurain R; Valvano MA; Santos-Preciado JI
    Pediatr Infect Dis J; 2020 Oct; 39(10):899-906. PubMed ID: 32453200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of a mutL mutation causing multilocus sequence typing-pulsed-field gel electrophoresis discrepancy among Pseudomonas aeruginosa isolates from a cystic fibrosis patient.
    García-Castillo M; Máiz L; Morosini MI; Rodríguez-Baños M; Suarez L; Fernández-Olmos A; Baquero F; Cantón R; del Campo R
    J Clin Microbiol; 2012 May; 50(5):1777-8. PubMed ID: 22322352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotypic and Phenotypic Diversity of Staphylococcus aureus Isolates from Cystic Fibrosis Patient Lung Infections and Their Interactions with Pseudomonas aeruginosa.
    Bernardy EE; Petit RA; Raghuram V; Alexander AM; Read TD; Goldberg JB
    mBio; 2020 Jun; 11(3):. PubMed ID: 32576671
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypermutability in environmental Pseudomonas aeruginosa and in populations causing pulmonary infection in individuals with cystic fibrosis.
    Kenna DT; Doherty CJ; Foweraker J; Macaskill L; Barcus VA; Govan JRW
    Microbiology (Reading); 2007 Jun; 153(Pt 6):1852-1859. PubMed ID: 17526842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotypic and phenotypic relatedness of Pseudomonas aeruginosa isolates among the major cystic fibrosis patient cohort in Italy.
    Cigana C; Melotti P; Baldan R; Pedretti E; Pintani E; Iansa P; De Fino I; Favari F; Bergamini G; Tridello G; Cirillo DM; Assael BM; Bragonzi A
    BMC Microbiol; 2016 Jul; 16(1):142. PubMed ID: 27400750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.